Epidemiology of Alzheimer's Disease and Dementia in Arab Countries: A Systematic Review.
Journal
Behavioural neurology
ISSN: 1875-8584
Titre abrégé: Behav Neurol
Pays: Netherlands
ID NLM: 8914585
Informations de publication
Date de publication:
2019
2019
Historique:
received:
26
01
2019
revised:
25
05
2019
accepted:
16
09
2019
entrez:
28
11
2019
pubmed:
28
11
2019
medline:
28
4
2020
Statut:
epublish
Résumé
Contrary to popular belief, the condition of dementia is not an actual discrete disease, but rather a group of symptoms, most notable of which is the disturbance of memory and social ability, often severe enough to impair daily functioning. As a result, it has been a major cause of functional deterioration among varying populations in the world. This study is aimed at reviewing the epidemiology of dementia in Arab countries in terms of its prevalence, distribution, and risk factors. A systematic literature review was conducted using articles published in PubMed, Embase, Scopus, and other local journals between 1990 and 2018. After applying the inclusion and exclusion criteria, a total of 18 studies were concluded to be eligible for the review. Prevalence studies demonstrated that dementia is indeed a prevalent condition in Arab countries, ranging between 1.1% and 2.3% among age groups of 50 years and older, as well as between 13.5% and 18.5% among age groups of 80 years and above. However, these results are not different from those of many other countries in the world. Moreover, prevalence was found to vary depending on sociodemographic characteristics. Major risk factors of dementia included hypertension, low income, and low education, while the risk of developing dementia is increased by obesity, diabetes mellitus, and cardiovascular risk factors. Despite the growing evidence regarding the epidemiological distribution and determinants of dementia worldwide, studies from the Arab region remain scarce. This systematic review highlights the need for population-based studies to provide necessary information for developing preventive and curative strategies specific to the Arab region.
Sections du résumé
BACKGROUND/OBJECTIVES
OBJECTIVE
Contrary to popular belief, the condition of dementia is not an actual discrete disease, but rather a group of symptoms, most notable of which is the disturbance of memory and social ability, often severe enough to impair daily functioning. As a result, it has been a major cause of functional deterioration among varying populations in the world. This study is aimed at reviewing the epidemiology of dementia in Arab countries in terms of its prevalence, distribution, and risk factors.
METHODS
METHODS
A systematic literature review was conducted using articles published in PubMed, Embase, Scopus, and other local journals between 1990 and 2018. After applying the inclusion and exclusion criteria, a total of 18 studies were concluded to be eligible for the review.
RESULTS
RESULTS
Prevalence studies demonstrated that dementia is indeed a prevalent condition in Arab countries, ranging between 1.1% and 2.3% among age groups of 50 years and older, as well as between 13.5% and 18.5% among age groups of 80 years and above. However, these results are not different from those of many other countries in the world. Moreover, prevalence was found to vary depending on sociodemographic characteristics. Major risk factors of dementia included hypertension, low income, and low education, while the risk of developing dementia is increased by obesity, diabetes mellitus, and cardiovascular risk factors. Despite the growing evidence regarding the epidemiological distribution and determinants of dementia worldwide, studies from the Arab region remain scarce.
CONCLUSION
CONCLUSIONS
This systematic review highlights the need for population-based studies to provide necessary information for developing preventive and curative strategies specific to the Arab region.
Identifiants
pubmed: 31772681
doi: 10.1155/2019/3935943
pmc: PMC6854962
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3935943Informations de copyright
Copyright © 2019 Ashraf El-Metwally et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest regarding the publication of this article.
Références
Dement Geriatr Cogn Disord. 1998 Nov-Dec;9(6):323-8
pubmed: 9769445
Lancet Neurol. 2008 Sep;7(9):812-26
pubmed: 18667359
Neuroepidemiology. 2010;34(2):99-105
pubmed: 20016220
Rev Neurol. 1999 Nov 16-30;29(10):908-11
pubmed: 10637837
Int J Environ Res Public Health. 2015 Jul 17;12(7):8281-94
pubmed: 26193295
Indian J Pediatr. 2012 Nov;79(11):1482-8
pubmed: 22562262
J Alzheimers Dis. 2012;29(2):431-9
pubmed: 22233764
J Alzheimers Dis. 2014;41(1):203-11
pubmed: 24583404
Ann Neurol. 2012 Nov;72(5):730-8
pubmed: 23280791
Neurobiol Aging. 2001 Jul-Aug;22(4):575-80
pubmed: 11445258
Age Ageing. 2007 Nov;36(6):619-24
pubmed: 17965036
Int J Geriatr Psychiatry. 2003 Aug;18(8):711-5
pubmed: 12891639
Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):63-7
pubmed: 12794381
Am J Alzheimers Dis Other Demen. 2008 Feb-Mar;23(1):67-76
pubmed: 18276959
Alzheimers Dement. 2013 Jan;9(1):63-75.e2
pubmed: 23305823
Acta Psychiatr Scand. 2001 Jul;104(1):4-11
pubmed: 11437743
J Mol Neurosci. 2002 Aug-Oct;19(1-2):239-45
pubmed: 12212789
Indian J Psychiatry. 2009 Jan;51 Suppl 1:S5-7
pubmed: 21416017
Dement Geriatr Cogn Disord. 2010;29(1):68-74
pubmed: 20130405
East Mediterr Health J. 2001 May;7(3):492-501
pubmed: 12690771
Lancet. 1998 Jun 20;351(9119):1840-3
pubmed: 9652667
Biomed Res Int. 2014;2014:908915
pubmed: 25089278
Endocrinol Metab Clin North Am. 2013 Sep;42(3):489-501
pubmed: 24011882
J Alzheimers Dis. 2010;20 Suppl 1:S167-74
pubmed: 20182054
Arch Intern Med. 2008 Oct 27;168(19):2070-80
pubmed: 18955635
Alzheimers Dement. 2015 Mar;11(3):310-320
pubmed: 24418058
Neuroepidemiology. 2010;35(4):291-7
pubmed: 20948236
J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1299-306
pubmed: 26294005
Lancet. 2014 Mar 1;383(9919):828-40
pubmed: 23927914
Prev Med Rep. 2017 Nov 24;9:1-5
pubmed: 29255666
Int J Neurosci. 2018 Jan;128(1):32-41
pubmed: 28657841
J Alzheimers Dis. 2015;45(1):117-26
pubmed: 25471192
Int J Geriatr Psychiatry. 2007 Apr;22(4):283-5
pubmed: 16977675
J Neurol Sci. 2002 Nov 15;203-204:73-6
pubmed: 12417360
Aust N Z J Psychiatry. 2003 Oct;37(5):606-12
pubmed: 14511090
J Clin Neurosci. 2009 Nov;16(11):1455-9
pubmed: 19748273
Lancet Neurol. 2006 Sep;5(9):735-41
pubmed: 16914401
Int J Geriatr Psychiatry. 2015 Mar;30(3):234-46
pubmed: 25504093
Neuroepidemiology. 2007;29(1-2):107-12
pubmed: 17940342
J Pak Med Assoc. 2011 Mar;61(3):216-21
pubmed: 21465930
Neurology. 2013 May 14;80(20):1888-94
pubmed: 23596063
Alzheimers Dement. 2017 Dec;13(12):1317-1326
pubmed: 28579315
Int J Geriatr Psychiatry. 2014 Aug;29(8):877-9
pubmed: 25043103
Ann Indian Acad Neurol. 2010 Dec;13(Suppl 2):S69-73
pubmed: 21369421
J Am Acad Psychiatry Law. 2014;42(2):159-64
pubmed: 24986342
Int Psychogeriatr. 2008 Apr;20(2):394-405
pubmed: 17559708
Int J Endocrinol. 2012;2012:902873
pubmed: 22851968
Int J Geriatr Psychiatry. 2004 Apr;19(4):344-51
pubmed: 15065227
BMJ. 2005 Jun 11;330(7504):1360
pubmed: 15863436
Per Med. 2019 Jan;16(1):15-23
pubmed: 30457419
BMJ. 1995 Apr 15;310(6985):970-3
pubmed: 7728032
Maturitas. 2014 Oct;79(2):196-201
pubmed: 24954700
Neuropsychiatr Dis Treat. 2017 Mar 06;13:715-720
pubmed: 28293113
World J Diabetes. 2016 Sep 15;7(17):412-22
pubmed: 27660698
Lancet Diabetes Endocrinol. 2014 Mar;2(3):246-55
pubmed: 24622755
Acta Neurol Scand. 1998 Aug;98(2):116-20
pubmed: 9724009
Clin Interv Aging. 2014;9:9-14
pubmed: 24353410
Eur J Neurol. 2001 Mar;8(2):119-23
pubmed: 11284991